HR Execs on the Move

Gambro Renal Products

www.gambro.com

 
Gambro Renal Products is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Gambro Renal Products is based in Lakewood, CO. You can find more information on Gambro Renal Products at www.gambro.com
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Revolution Health Group

Revolution Health Group LLC is a Washington, DC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Mental Health Association of South Central Kansas

The Mental Health Association of South Central Kansas (MHASCK) has been serving the Sedgwick County Community since 1957. We are a 501(c)3 non-profit organization, a United Way agency and an affiliate of Sedgwick County COMCARE. We believe these

First Health Group Corporation

First Health Group Corporation is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nature`s Sunshine

Nature`s Sunshine Products manufactures and markets tablets and encapsulated herbal products, high-quality natural vitamins, food supplements, skin care and other complementary products. The Company has operations in the United States, South Korea, Mexico, Venezuela, Japan, Brazil, Canada, Central America, Colombia, Ecuador, Peru, the United Kingdom, Israel and Chile. The Company also exports its products to several other countries, including Argentina, Australia, Malaysia, New Zealand, Norway and the Russian Federation.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.